APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pets Anti-infective Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pets Anti-infective Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025196 pages

Choose your research edition.

Industry ResearchPets Anti-infective Drugs Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Pets Anti-infective Drugs Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Pets Anti-infective Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pets Anti-infective Drugs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Pets Anti-infective Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Pets Anti-infective Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pets Anti-infective Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pets Anti-infective Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pets Anti-infective Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pets Anti-infective Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pets Anti-infective Drugs include Bimeda Animal Health, Ceva Santé Animale, Dechra Veterinary Products, Elanco, Norbrook, Ouro Fino Saude, Vetoquinol, Virbac and Zoetis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pets Anti-infective Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pets Anti-infective Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pets Anti-infective Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pets Anti-infective Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Pets Anti-infective Drugs Segment by Company

Bimeda Animal Health

Ceva Santé Animale

Dechra Veterinary Products

Elanco

Norbrook

Ouro Fino Saude

Vetoquinol

Virbac

Zoetis

Zhejiang Hisun Animal Healthcare Products

Hanvet Pet Health

Wuhan Hvsen Biotechnology

Nanjing Jindun Animal

Merck

Wuhan Chopperlvya

Pets Anti-infective Drugs Segment by Type

Injection

External Use

Internal Use

Pets Anti-infective Drugs Segment by Application

Dog

Cat

Others

Pets Anti-infective Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pets Anti-infective Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pets Anti-infective Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pets Anti-infective Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pets Anti-infective Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pets Anti-infective Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pets Anti-infective Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pets Anti-infective Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pets Anti-infective Drugs Industry Trends Table 2. Pets Anti-infective Drugs Industry Drivers Table 3. Pets Anti-infective Drugs Industry Opportunities and Challenges Table 4. Pets Anti-infective Drugs Industry Restraints Table 5. Global Pets Anti-infective Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pets Anti-infective Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pets Anti-infective Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Pets Anti-infective Drugs Sales Market Share by Manufacturers Table 9. Global Pets Anti-infective Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Pets Anti-infective Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pets Anti-infective Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pets Anti-infective Drugs Manufacturers, Product Type & Application Table 13. Global Pets Anti-infective Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pets Anti-infective Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Injection Table 17. Major Manufacturers of External Use Table 18. Major Manufacturers of Internal Use Table 19. Global Pets Anti-infective Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Pets Anti-infective Drugs Sales by Type (2021-2026) & (K Units) Table 21. Global Pets Anti-infective Drugs Sales by Type (2027-2032) & (K Units) Table 22. Global Pets Anti-infective Drugs Sales Market Share by Type (2021-2026) Table 23. Global Pets Anti-infective Drugs Sales Market Share by Type (2027-2032) Table 24. Global Pets Anti-infective Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Pets Anti-infective Drugs Revenue by Type (2021-2026) & (K Units) Table 26. Global Pets Anti-infective Drugs Revenue by Type (2027-2032) & (K Units) Table 27. Global Pets Anti-infective Drugs Revenue Market Share by Type (2021-2026) Table 28. Global Pets Anti-infective Drugs Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Dog Table 30. Major Manufacturers of Cat Table 31. Major Manufacturers of Others Table 32. Global Pets Anti-infective Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Pets Anti-infective Drugs Sales by Application (2021-2026) & (K Units) Table 34. Global Pets Anti-infective Drugs Sales by Application (2027-2032) & (K Units) Table 35. Global Pets Anti-infective Drugs Sales Market Share by Application (2021-2026) Table 36. Global Pets Anti-infective Drugs Sales Market Share by Application (2027-2032) Table 37. Global Pets Anti-infective Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Pets Anti-infective Drugs Revenue by Application (2021-2026) & (K Units) Table 39. Global Pets Anti-infective Drugs Revenue by Application (2027-2032) & (K Units) Table 40. Global Pets Anti-infective Drugs Revenue Market Share by Application (2021-2026) Table 41. Global Pets Anti-infective Drugs Revenue Market Share by Application (2027-2032) Table 42. Global Pets Anti-infective Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Pets Anti-infective Drugs Sales by Region (2021-2026) & (K Units) Table 44. Global Pets Anti-infective Drugs Sales Market Share by Region (2021-2026) Table 45. Global Pets Anti-infective Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Pets Anti-infective Drugs Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Pets Anti-infective Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Pets Anti-infective Drugs Sales by Country (2021-2026) & (K Units) Table 49. North America Pets Anti-infective Drugs Sales by Country (2027-2032) & (K Units) Table 50. Europe Pets Anti-infective Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Pets Anti-infective Drugs Sales by Country (2021-2026) & (K Units) Table 52. Europe Pets Anti-infective Drugs Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Pets Anti-infective Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Pets Anti-infective Drugs Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Pets Anti-infective Drugs Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Pets Anti-infective Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Pets Anti-infective Drugs Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Pets Anti-infective Drugs Sales by Country (2027-2032) & (K Units) Table 59. Global Pets Anti-infective Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Pets Anti-infective Drugs Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Pets Anti-infective Drugs Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Pets Anti-infective Drugs Revenue Market Share by Region (2021-2026) Table 63. Global Pets Anti-infective Drugs Revenue Market Share by Region (2027-2032) Table 64. Bimeda Animal Health Company Information Table 65. Bimeda Animal Health Business Overview Table 66. Bimeda Animal Health Pets Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Bimeda Animal Health Pets Anti-infective Drugs Product Portfolio Table 68. Bimeda Animal Health Recent Development Table 69. Ceva Santé Animale Company Information Table 70. Ceva Santé Animale Business Overview Table 71. Ceva Santé Animale Pets Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Ceva Santé Animale Pets Anti-infective Drugs Product Portfolio Table 73. Ceva Santé Animale Recent Development Table 74. Dechra Veterinary Products Company Information Table 75. Dechra Veterinary Products Business Overview Table 76. Dechra Veterinary Products Pets Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Dechra Veterinary Products Pets Anti-infective Drugs Product Portfolio Table 78. Dechra Veterinary Products Recent Development Table 79. Elanco Company Information Table 80. Elanco Business Overview Table 81. Elanco Pets Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Elanco Pets Anti-infective Drugs Product Portfolio Table 83. Elanco Recent Development Table 84. Norbrook Company Information Table 85. Norbrook Business Overview Table 86. Norbrook Pets Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Norbrook Pets Anti-infective Drugs Product Portfolio Table 88. Norbrook Recent Development Table 89. Ouro Fino Saude Company Information Table 90. Ouro Fino Saude Business Overview Table 91. Ouro Fino Saude Pets Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Ouro Fino Saude Pets Anti-infective Drugs Product Portfolio Table 93. Ouro Fino Saude Recent Development Table 94. Vetoquinol Company Information Table 95. Vetoquinol Business Overview Table 96. Vetoquinol Pets Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Vetoquinol Pets Anti-infective Drugs Product Portfolio Table 98. Vetoquinol Recent Development Table 99. Virbac Company Information Table 100. Virbac Business Overview Table 101. Virbac Pets Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Virbac Pets Anti-infective Drugs Product Portfolio Table 103. Virbac Recent Development Table 104. Zoetis Company Information Table 105. Zoetis Business Overview Table 106. Zoetis Pets Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Zoetis Pets Anti-infective Drugs Product Portfolio Table 108. Zoetis Recent Development Table 109. Zhejiang Hisun Animal Healthcare Products Company Information Table 110. Zhejiang Hisun Animal Healthcare Products Business Overview Table 111. Zhejiang Hisun Animal Healthcare Products Pets Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Zhejiang Hisun Animal Healthcare Products Pets Anti-infective Drugs Product Portfolio Table 113. Zhejiang Hisun Animal Healthcare Products Recent Development Table 114. Hanvet Pet Health Company Information Table 115. Hanvet Pet Health Business Overview Table 116. Hanvet Pet Health Pets Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Hanvet Pet Health Pets Anti-infective Drugs Product Portfolio Table 118. Hanvet Pet Health Recent Development Table 119. Wuhan Hvsen Biotechnology Company Information Table 120. Wuhan Hvsen Biotechnology Business Overview Table 121. Wuhan Hvsen Biotechnology Pets Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Wuhan Hvsen Biotechnology Pets Anti-infective Drugs Product Portfolio Table 123. Wuhan Hvsen Biotechnology Recent Development Table 124. Nanjing Jindun Animal Company Information Table 125. Nanjing Jindun Animal Business Overview Table 126. Nanjing Jindun Animal Pets Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Nanjing Jindun Animal Pets Anti-infective Drugs Product Portfolio Table 128. Nanjing Jindun Animal Recent Development Table 129. Merck Company Information Table 130. Merck Business Overview Table 131. Merck Pets Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Merck Pets Anti-infective Drugs Product Portfolio Table 133. Merck Recent Development Table 134. Wuhan Chopperlvya Company Information Table 135. Wuhan Chopperlvya Business Overview Table 136. Wuhan Chopperlvya Pets Anti-infective Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Wuhan Chopperlvya Pets Anti-infective Drugs Product Portfolio Table 138. Wuhan Chopperlvya Recent Development Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Pets Anti-infective Drugs Distributors List Table 142. Pets Anti-infective Drugs Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Pets Anti-infective Drugs Product Image Figure 2. Global Pets Anti-infective Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pets Anti-infective Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Pets Anti-infective Drugs Sales (2021-2032) & (K Units) Figure 5. Global Pets Anti-infective Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pets Anti-infective Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Injection Image Figure 9. External Use Image Figure 10. Internal Use Image Figure 11. Global Pets Anti-infective Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Pets Anti-infective Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Pets Anti-infective Drugs Sales Market Share by Type (2021-2032) Figure 14. Global Pets Anti-infective Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Pets Anti-infective Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Pets Anti-infective Drugs Revenue Market Share by Type (2021-2032) Figure 17. Dog Image Figure 18. Cat Image Figure 19. Others Image Figure 20. Global Pets Anti-infective Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Pets Anti-infective Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Pets Anti-infective Drugs Sales Market Share by Application (2021-2032) Figure 23. Global Pets Anti-infective Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Pets Anti-infective Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Pets Anti-infective Drugs Revenue Market Share by Application (2021-2032) Figure 26. North America Pets Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Pets Anti-infective Drugs Sales Market Share by Country (2021-2032) Figure 28. U.S. Pets Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Pets Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Pets Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Pets Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Pets Anti-infective Drugs Sales Market Share by Country (2021-2032) Figure 33. Germany Pets Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Pets Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Pets Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Pets Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Pets Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Pets Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Pets Anti-infective Drugs Sales Market Share by Country (2021-2032) Figure 40. China Pets Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Pets Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Pets Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Pets Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Pets Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Pets Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Pets Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Pets Anti-infective Drugs Sales Market Share by Country (2021-2032) Figure 48. Brazil Pets Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Pets Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Pets Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Pets Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Pets Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Pets Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Pets Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Pets Anti-infective Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Pets Anti-infective Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Pets Anti-infective Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Pets Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Figure 59. North America Pets Anti-infective Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Pets Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Figure 61. Europe Pets Anti-infective Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Pets Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Pets Anti-infective Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Pets Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Pets Anti-infective Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Pets Anti-infective Drugs Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Pets Anti-infective Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • External Use
  • Internal Use
Applications
  • Dog
  • Cat
  • Others
Companies covered
  • Bimeda Animal Health
  • Ceva Santé Animale
  • Dechra Veterinary Products
  • Elanco
  • Norbrook
  • Ouro Fino Saude
  • Vetoquinol
  • Virbac
  • Zoetis
  • Zhejiang Hisun Animal Healthcare Products
  • Hanvet Pet Health
  • Wuhan Hvsen Biotechnology
  • Nanjing Jindun Animal
  • Merck
  • Wuhan Chopperlvya

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pets Anti-infective Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pets Anti-infective Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pets Anti-infective Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pets Anti-infective Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pets Anti-infective Drugs Market Dynamics
  1. 2.1 Pets Anti-infective Drugs Industry Trends
  2. 2.2 Pets Anti-infective Drugs Industry Drivers
  3. 2.3 Pets Anti-infective Drugs Industry Opportunities and Challenges
  4. 2.4 Pets Anti-infective Drugs Industry Restraints
3 Pets Anti-infective Drugs Market by Manufacturers
  1. 3.1 Global Pets Anti-infective Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pets Anti-infective Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pets Anti-infective Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pets Anti-infective Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pets Anti-infective Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pets Anti-infective Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Pets Anti-infective Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pets Anti-infective Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pets Anti-infective Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pets Anti-infective Drugs Tier 1, Tier 2, and Tier 3
4 Pets Anti-infective Drugs Market by Type
  1. 4.1 Pets Anti-infective Drugs Type Introduction
  2. 4.1.1 Injection
  3. 4.1.2 External Use
  4. 4.1.3 Internal Use
  5. 4.2 Global Pets Anti-infective Drugs Sales by Type
  6. 4.2.1 Global Pets Anti-infective Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Pets Anti-infective Drugs Sales by Type (2021-2032)
  8. 4.2.3 Global Pets Anti-infective Drugs Sales Market Share by Type (2021-2032)
  9. 4.3 Global Pets Anti-infective Drugs Revenue by Type
  10. 4.3.1 Global Pets Anti-infective Drugs Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Pets Anti-infective Drugs Revenue by Type (2021-2032)
  12. 4.3.3 Global Pets Anti-infective Drugs Revenue Market Share by Type (2021-2032)
5 Pets Anti-infective Drugs Market by Application
  1. 5.1 Pets Anti-infective Drugs Application Introduction
  2. 5.1.1 Dog
  3. 5.1.2 Cat
  4. 5.1.3 Others
  5. 5.2 Global Pets Anti-infective Drugs Sales by Application
  6. 5.2.1 Global Pets Anti-infective Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pets Anti-infective Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Pets Anti-infective Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Pets Anti-infective Drugs Revenue by Application
  10. 5.3.1 Global Pets Anti-infective Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pets Anti-infective Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Pets Anti-infective Drugs Revenue Market Share by Application (2021-2032)
6 Global Pets Anti-infective Drugs Sales by Region
  1. 6.1 Global Pets Anti-infective Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pets Anti-infective Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Pets Anti-infective Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Pets Anti-infective Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pets Anti-infective Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pets Anti-infective Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pets Anti-infective Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pets Anti-infective Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pets Anti-infective Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pets Anti-infective Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pets Anti-infective Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pets Anti-infective Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pets Anti-infective Drugs Revenue by Region
  1. 7.1 Global Pets Anti-infective Drugs Revenue by Region
  2. 7.1.1 Global Pets Anti-infective Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pets Anti-infective Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Pets Anti-infective Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Pets Anti-infective Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pets Anti-infective Drugs Revenue (2021-2032)
  8. 7.2.2 North America Pets Anti-infective Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pets Anti-infective Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Pets Anti-infective Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pets Anti-infective Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pets Anti-infective Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pets Anti-infective Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pets Anti-infective Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Bimeda Animal Health
  2. 8.1.1 Bimeda Animal Health Company Information
  3. 8.1.2 Bimeda Animal Health Business Overview
  4. 8.1.3 Bimeda Animal Health Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bimeda Animal Health Pets Anti-infective Drugs Product Portfolio
  6. 8.1.5 Bimeda Animal Health Recent Developments
  7. 8.2 Ceva Santé Animale
  8. 8.2.1 Ceva Santé Animale Company Information
  9. 8.2.2 Ceva Santé Animale Business Overview
  10. 8.2.3 Ceva Santé Animale Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Ceva Santé Animale Pets Anti-infective Drugs Product Portfolio
  12. 8.2.5 Ceva Santé Animale Recent Developments
  13. 8.3 Dechra Veterinary Products
  14. 8.3.1 Dechra Veterinary Products Company Information
  15. 8.3.2 Dechra Veterinary Products Business Overview
  16. 8.3.3 Dechra Veterinary Products Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Dechra Veterinary Products Pets Anti-infective Drugs Product Portfolio
  18. 8.3.5 Dechra Veterinary Products Recent Developments
  19. 8.4 Elanco
  20. 8.4.1 Elanco Company Information
  21. 8.4.2 Elanco Business Overview
  22. 8.4.3 Elanco Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Elanco Pets Anti-infective Drugs Product Portfolio
  24. 8.4.5 Elanco Recent Developments
  25. 8.5 Norbrook
  26. 8.5.1 Norbrook Company Information
  27. 8.5.2 Norbrook Business Overview
  28. 8.5.3 Norbrook Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Norbrook Pets Anti-infective Drugs Product Portfolio
  30. 8.5.5 Norbrook Recent Developments
  31. 8.6 Ouro Fino Saude
  32. 8.6.1 Ouro Fino Saude Company Information
  33. 8.6.2 Ouro Fino Saude Business Overview
  34. 8.6.3 Ouro Fino Saude Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Ouro Fino Saude Pets Anti-infective Drugs Product Portfolio
  36. 8.6.5 Ouro Fino Saude Recent Developments
  37. 8.7 Vetoquinol
  38. 8.7.1 Vetoquinol Company Information
  39. 8.7.2 Vetoquinol Business Overview
  40. 8.7.3 Vetoquinol Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Vetoquinol Pets Anti-infective Drugs Product Portfolio
  42. 8.7.5 Vetoquinol Recent Developments
  43. 8.8 Virbac
  44. 8.8.1 Virbac Company Information
  45. 8.8.2 Virbac Business Overview
  46. 8.8.3 Virbac Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Virbac Pets Anti-infective Drugs Product Portfolio
  48. 8.8.5 Virbac Recent Developments
  49. 8.9 Zoetis
  50. 8.9.1 Zoetis Company Information
  51. 8.9.2 Zoetis Business Overview
  52. 8.9.3 Zoetis Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Zoetis Pets Anti-infective Drugs Product Portfolio
  54. 8.9.5 Zoetis Recent Developments
  55. 8.10 Zhejiang Hisun Animal Healthcare Products
  56. 8.10.1 Zhejiang Hisun Animal Healthcare Products Company Information
  57. 8.10.2 Zhejiang Hisun Animal Healthcare Products Business Overview
  58. 8.10.3 Zhejiang Hisun Animal Healthcare Products Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Zhejiang Hisun Animal Healthcare Products Pets Anti-infective Drugs Product Portfolio
  60. 8.10.5 Zhejiang Hisun Animal Healthcare Products Recent Developments
  61. 8.11 Hanvet Pet Health
  62. 8.11.1 Hanvet Pet Health Company Information
  63. 8.11.2 Hanvet Pet Health Business Overview
  64. 8.11.3 Hanvet Pet Health Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hanvet Pet Health Pets Anti-infective Drugs Product Portfolio
  66. 8.11.5 Hanvet Pet Health Recent Developments
  67. 8.12 Wuhan Hvsen Biotechnology
  68. 8.12.1 Wuhan Hvsen Biotechnology Company Information
  69. 8.12.2 Wuhan Hvsen Biotechnology Business Overview
  70. 8.12.3 Wuhan Hvsen Biotechnology Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Wuhan Hvsen Biotechnology Pets Anti-infective Drugs Product Portfolio
  72. 8.12.5 Wuhan Hvsen Biotechnology Recent Developments
  73. 8.13 Nanjing Jindun Animal
  74. 8.13.1 Nanjing Jindun Animal Company Information
  75. 8.13.2 Nanjing Jindun Animal Business Overview
  76. 8.13.3 Nanjing Jindun Animal Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Nanjing Jindun Animal Pets Anti-infective Drugs Product Portfolio
  78. 8.13.5 Nanjing Jindun Animal Recent Developments
  79. 8.14 Merck
  80. 8.14.1 Merck Company Information
  81. 8.14.2 Merck Business Overview
  82. 8.14.3 Merck Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Merck Pets Anti-infective Drugs Product Portfolio
  84. 8.14.5 Merck Recent Developments
  85. 8.15 Wuhan Chopperlvya
  86. 8.15.1 Wuhan Chopperlvya Company Information
  87. 8.15.2 Wuhan Chopperlvya Business Overview
  88. 8.15.3 Wuhan Chopperlvya Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Wuhan Chopperlvya Pets Anti-infective Drugs Product Portfolio
  90. 8.15.5 Wuhan Chopperlvya Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pets Anti-infective Drugs Value Chain Analysis
  2. 9.1.1 Pets Anti-infective Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pets Anti-infective Drugs Production Mode & Process
  6. 9.2 Pets Anti-infective Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pets Anti-infective Drugs Distributors
  9. 9.2.3 Pets Anti-infective Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst